41239-40-1Relevant articles and documents
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
-
Page/Page column 743, (2018/10/25)
Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula (I), or a stereoisomer thereof; and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.
SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1
-
Paragraph 00608, (2016/04/26)
Provided herein are small molecule neurotensin receptor agonists, compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.
KINASE INHIBITORS
-
Paragraph 0830; 0831, (2013/06/27)
Compounds of formula (I) and pharmaceutically acceptable salts thereof: wherein R2, W, A, Y and R1 are as defined in the specification, are p38 MAPK inhibitors, and are useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.